Antibe Therapeutics Inc.

OTCPK:ATBP.F Stock Report

Market Cap: US$11.4m

Antibe Therapeutics Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Dan Legault

Chief executive officer

CA$784.9k

Total compensation

CEO salary percentage65.6%
CEO tenure15yrs
CEO ownership2.1%
Management average tenure4.1yrs
Board average tenureno data

Recent management updates

Recent updates

CEO Compensation Analysis

How has Dan Legault's remuneration changed compared to Antibe Therapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-CA$18m

Sep 30 2023n/an/a

-CA$18m

Jun 30 2023n/an/a

-CA$19m

Mar 31 2023CA$785kCA$515k

-CA$19m

Dec 31 2022n/an/a

-CA$21m

Sep 30 2022n/an/a

-CA$22m

Jun 30 2022n/an/a

-CA$24m

Mar 31 2022CA$715kCA$443k

-CA$25m

Dec 31 2021n/an/a

-CA$26m

Sep 30 2021n/an/a

-CA$26m

Jun 30 2021n/an/a

-CA$25m

Mar 31 2021CA$3mCA$357k

-CA$24m

Dec 31 2020n/an/a

-CA$25m

Sep 30 2020n/an/a

-CA$23m

Jun 30 2020n/an/a

-CA$21m

Mar 31 2020CA$1mCA$311k

-CA$19m

Dec 31 2019n/an/a

-CA$17m

Sep 30 2019n/an/a

-CA$16m

Jun 30 2019n/an/a

-CA$13m

Mar 31 2019CA$2mCA$311k

-CA$13m

Dec 31 2018n/an/a

-CA$11m

Sep 30 2018n/an/a

-CA$9m

Jun 30 2018n/an/a

-CA$8m

Mar 31 2018CA$273kCA$273k

-CA$7m

Compensation vs Market: Dan's total compensation ($USD570.45K) is about average for companies of similar size in the US market ($USD667.63K).

Compensation vs Earnings: Dan's compensation has increased whilst the company is unprofitable.

CEO

Dan Legault (65 yo)

15yrs

Tenure

CA$784,861

Compensation

Mr. Daniel Marcel Legault, also known as Dan, J.D., L.L.B, served as the Independent Chairman at Klinik Health Ventures Corp. and served as its Independent Director since April 17, 2019 and served as its P...

Leadership Team

NamePositionTenureCompensationOwnership
Daniel Legault
President15yrsCA$784.86k2.13%
CA$ 242.2k
Alain Wilson
Chief Financial Officer8.4yrsCA$219.93k0.13%
CA$ 14.8k
Scott Curtis
Chief Operating Officer1.8yrsCA$316.21k0.22%
CA$ 24.7k
David Vaughan
Chief Development Officerno dataCA$423.61k0.050%
CA$ 5.7k
Joseph Stauffer
Chief Medical Officer4.1yrsCA$1.13m0.48%
CA$ 54.6k
Ana Stegic
Executive Director of Clinical Operations3yrsCA$263.34k0.079%
CA$ 8.9k
Christina Cameron
Vice President of Investor Relationsno datano datano data
Philip Stern
Vice President of Communicationsno datano datano data

4.1yrs

Average Tenure

65yo

Average Age

Experienced Management: ATBP.F's management team is considered experienced (4.1 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.